Intensity Therapeutics Announces New Clinical Data Presentation for its Lead Asset, INT230-6, in Breast Cancer, at the 2021 San Antonio Breast Cancer Symposium in December

Press/Media

PeriodNov 30 2021

Media coverage

1

Media coverage

  • TitleIntensity Therapeutics Announces New Clinical Data Presentation for its Lead Asset, INT230-6, in Breast Cancer, at the 2021 San Antonio Breast Cancer Symposium in December
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date11/30/21
    PersonsAnthony J. Olszanski